A remedy against obesity? The role of lactoferrin in the metabolism of glucose and lipids
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Obesity, dyslipidemia, hyperglycemia/type II diabetes and hypertension together constitute the so-called metabolic syndrome. Frequency of occurrence of these serious metabolic disturbances is associated with life style and is on the rise in prosperous industrialized countries. These diseases represent not only a serious health problem but also social and economic ones, and involve in prophylaxis and treatment various specialists (physicians, dieticians and psychologists). For about two decades research has been conducted on the possibility to apply milk-derived proteins in prevention and treatment of the above mentioned metabolic diseases. Lactoferrin (LF), a protein present in milk and excretory fluids of mammals, is one of the most intensively studied milk proteins for therapeutic application. Initial trials revealing an advantageous effect of LF on lipid metabolism and obesity enrolled only a few volunteers and were performed in Japan in 2003. Subsequent trials were conducted on animals as well as in clinics, and the positive results were supported by in vitro tests. After oral administration of LF, decreases of body weight, waist measurement, visceral fat tissue, plasma and liver fatty acid concentrations, triglycerides and cholesterol were registered. The mechanism of LF action may involve several processes, such as inhibition of adipogenesis, decrease of dietary triglyceride absorption, elevation of HDL cholesterol possessing anti-atherogenic properties, inhibition of accumulation of oxidized LDL cholesterol forms in macrophages and protection against formation of foam cells. LF also increases the susceptibility of cells to insulin action, including in conditions when the response to insulin is lowered (during inflammation). In addition, LF regulates activity of insulin-like growth factor (IGF). The data collected to date indicate that LF is a promising, completely nontoxic, natural remedy which (as for example a food supplement) may be applied in long-term prophylaxis and therapy of metabolic disturbances, such as dyslipidemia, obesity and insulin resistance/type II diabetes.
Authors and Affiliations
Jolanta Artym
Keywords
Related Articles
- EP ID EP66829
- DOI -
- Views 179
- Downloads 0
Zaburzenia immunologiczne w sepsie oraz ich leczenie jako istotny problem współczesnej intensywnej terapii
Stan badań dotyczących genetyki psychiatrycznej w Polsce i na świecie – raport z ostatnich lat
The aim of this article was to review the results of research carried out in recent years in relation to genetic studies in psychiatry. The authors’ focus is on the selected disorders, with particular emphasis on the rep...
Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system
Interleukin 33 (IL-33) is a member of the IL-1 cytokin family. It is expressed by various cells and tissues, mainly epithelial and endothelial cells. It is a cytokine with dual function. It may act both as a traditional...
Are KIR genes associated with clinical parameters in the course of periodontitis?
Introduction: Periodontitis is a common chronic inflammatory disease. It seems that natural killer (NK) cells play a role in the pathogenesis of periodontitis. KIRs are a family of inhibitory or activating receptors expr...
Drugi kod, czyli co determinuje regiony aktywności transkrypcyjnej oraz miejsca inicjacji replikacji
Komórki poszczególnych tkanek, chociaż zawierają identyczny materiał genetyczny, różnią się jednak kodami epigenetycznymi odpowiedzialnymi za odmienne wzorce ekspresji genów. Kody takie, poprzez wpływ na strukturę chroma...